NASDAQ:IOBT IO Biotech - IOBT Institutional Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.94 -0.06 (-3.00%) (As of 03/27/2023 03:59 PM ET) Add Compare Share Share Today's Range$1.90▼$2.0950-Day Range$1.98▼$2.9852-Week Range$1.90▼$9.77Volume53,619 shsAverage Volume75,944 shsMarket Capitalization$55.91 millionP/E RatioN/ADividend YieldN/APrice Target$10.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for IO Biotech (NASDAQ:IOBT)CurrentInstitutional OwnershipPercentage53.23%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$4.76 MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$2.60 M Skip Chart & View Institutional Buying and Selling Data IOBT Institutional Buying and Selling by Quarter Get IOBT Insider Trade Alerts Want to know when executives and insiders are buying or selling IO Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IO Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2023Millennium Management LLC20,554$47K0.0%-46.4%0.071% 2/15/2023Morgan Stanley29,060$67K0.0%+31.7%0.101% 2/14/2023RA Capital Management L.P.1,127,260$2.59M0.1%-39.3%3.911% 2/13/2023Renaissance Technologies LLC24,200$56K0.0%+31.4%0.084% 2/10/2023Bank of America Corp DE1,854,185$4.27M0.0%+18,441.9%6.434% 11/15/2022Citadel Advisors LLC42,180$0.11M0.0%+192.4%0.146% 11/14/2022Renaissance Technologies LLC18,423$50K0.0%N/A0.064% 11/14/2022Psagot Value Holdings Ltd. Israel40,846$0.11M0.0%N/A0.142% 11/2/2022Victory Capital Management Inc.43,741$0.12M0.0%N/A0.152% 8/15/2022Millennium Management LLC46,231$0.22M0.0%-36.4%0.160% 5/17/2022Jane Street Group LLC14,280$76K0.0%N/A0.050% 5/13/2022Ergoteles LLC11,126$59K0.0%N/A0.039% 5/13/2022Vanguard Group Inc.62,234$0.33M0.0%-69.7%0.216% 2/15/2022Samsara BioCapital LLC1,120,437$7.17M1.4%N/A3.888% 2/15/2022Capital World Investors1,235,000$8.11M0.0%N/A4.286% 2/14/2022Soleus Capital Management L.P.672,734$4.31M0.4%N/A2.335% 2/14/2022Novo Holdings A S3,277,932$20.98M1.0%N/A11.376% (Data available from 1/1/2016 forward) IOBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IOBT shares? During the previous two years, 15 institutional investors and hedge funds held shares of IO Biotech. The most heavily invested institutionals were Novo Holdings A S ($20.98M), Capital World Investors ($8.11M), Samsara BioCapital LLC ($7.17M), Soleus Capital Management L.P. ($4.31M), Bank of America Corp DE ($4.27M), RA Capital Management L.P. ($2.59M), and Vanguard Group Inc. ($0.33M).Learn more on IOBT's institutional investors. What percentage of IO Biotech stock is owned by institutional investors? 53.23% of IO Biotech stock is owned by institutional investors. Learn more on IOBT's institutional investor holdings. Which institutional investors have been buying IO Biotech stock? Of the 12 institutional investors that purchased IO Biotech stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Novo Holdings A S ($3.28M), Bank of America Corp DE ($1.84M), Capital World Investors ($1.24M), Samsara BioCapital LLC ($1.12M), Soleus Capital Management L.P. ($0.67M), Victory Capital Management Inc. ($43.74K), and Psagot Value Holdings Ltd. Israel ($40.85K). How much institutional buying is happening at IO Biotech? Institutional investors have bought a total of 8,319,235 shares in the last 24 months. This purchase volume represents approximately $45.12M in transactions. Which IO Biotech major shareholders have been selling company stock? The following institutional investors have sold IO Biotech stock in the last 24 months: RA Capital Management L.P. ($0.73M), Vanguard Group Inc. ($0.14M), and Millennium Management LLC ($44.27K). How much institutional selling is happening at IO Biotech? Institutional investors have sold a total of 917,726 shares in the last 24 months. This volume of shares sold represents approximately $2.60M in transactions. This page (NASDAQ:IOBT) was last updated on 3/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.